ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA) — Market Cap & Net Worth
Market Cap & Net Worth: ALIB.HL.INF.TEC.UNSP.ADR (TWYA)
ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA) has a market capitalization of $8.42 Billion (€7.20 Billion) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #2534 globally and #517 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ALIB.HL.INF.TEC.UNSP.ADR's stock price €8.95 by its total outstanding shares 804642562 (804.64 Million).
ALIB.HL.INF.TEC.UNSP.ADR Market Cap History: 2021 to 2026
ALIB.HL.INF.TEC.UNSP.ADR's market capitalization history from 2021 to 2026. Data shows change from $12.79 Billion to $8.42 Billion (-28.53% CAGR).
ALIB.HL.INF.TEC.UNSP.ADR Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ALIB.HL.INF.TEC.UNSP.ADR's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TWYA by Market Capitalization
Companies near ALIB.HL.INF.TEC.UNSP.ADR in the global market cap rankings as of May 2, 2026.
Key companies related to ALIB.HL.INF.TEC.UNSP.ADR by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1408 globally with a market cap of $17.90 Billion USD ( €15.31 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2179 globally with a market cap of $10.37 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2723 globally with a market cap of $7.53 Billion USD ( R$38.36 Billion BRL).
- Yifeng Pharmacy (SHG:603939): Ranked #4079 globally with a market cap of $4.12 Billion USD ( CN¥28.13 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1408 | JD HEALTH INTL LTD | F:8ZN | $17.90 Billion | €4.90 |
| #2179 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2723 | Raia Drogasil S.A | SA:RADL3 | $7.53 Billion | R$21.94 |
| #4079 | Yifeng Pharmacy | SHG:603939 | $4.12 Billion | CN¥23.20 |
ALIB.HL.INF.TEC.UNSP.ADR Historical Marketcap From 2021 to 2026
Between 2021 and today, ALIB.HL.INF.TEC.UNSP.ADR's market cap moved from $12.79 Billion to $ 8.42 Billion, with a yearly change of -28.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €8.42 Billion | -9.14% |
| 2025 | €9.27 Billion | +18.67% |
| 2024 | €7.81 Billion | -9.78% |
| 2023 | €8.65 Billion | -41.77% |
| 2022 | €14.86 Billion | +16.18% |
| 2021 | €12.79 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of ALIB.HL.INF.TEC.UNSP.ADR was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.42 Billion USD |
| MoneyControl | $8.42 Billion USD |
| MarketWatch | $8.42 Billion USD |
| marketcap.company | $8.42 Billion USD |
| Reuters | $8.42 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ALIB.HL.INF.TEC.UNSP.ADR
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and famil… Read more